NCT01661192View on ClinicalTrials.gov

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Type 1 DiabetesBeta Cell Preservation
Interventions
DRUG

AAT( Alpha 1 Antitrypsin)

Trial Locations (2)

49202

Schneider Children's Medical Center, Petah Tikva

Unknown

Assaf Haroffeh Medical Center, Ẕerifin

All Listed Sponsors
collaborator

Kamada, Ltd.

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT01661192 - Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes | Biotech Hunter | Biotech Hunter